JP2005514321A5 - - Google Patents

Download PDF

Info

Publication number
JP2005514321A5
JP2005514321A5 JP2002582991A JP2002582991A JP2005514321A5 JP 2005514321 A5 JP2005514321 A5 JP 2005514321A5 JP 2002582991 A JP2002582991 A JP 2002582991A JP 2002582991 A JP2002582991 A JP 2002582991A JP 2005514321 A5 JP2005514321 A5 JP 2005514321A5
Authority
JP
Japan
Prior art keywords
attached
molecule
multifunctional linker
ligand
linker unit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002582991A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005514321A (ja
JP5398945B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/012565 external-priority patent/WO2002085418A2/en
Publication of JP2005514321A publication Critical patent/JP2005514321A/ja
Publication of JP2005514321A5 publication Critical patent/JP2005514321A5/ja
Application granted granted Critical
Publication of JP5398945B2 publication Critical patent/JP5398945B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002582991A 2001-04-23 2002-04-23 TcおよびRe標識放射活性グリコシル化オクトレオチド誘導体 Expired - Fee Related JP5398945B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01201466.8 2001-04-23
EP01201466 2001-04-23
PCT/US2002/012565 WO2002085418A2 (en) 2001-04-23 2002-04-23 Tc and re labeler radioactive glycosylated octreotide derivatives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009228998A Division JP2010001313A (ja) 2001-04-23 2009-09-30 TcおよびRe標識放射活性グリコシル化オクトレオチド誘導体

Publications (3)

Publication Number Publication Date
JP2005514321A JP2005514321A (ja) 2005-05-19
JP2005514321A5 true JP2005514321A5 (https=) 2006-01-05
JP5398945B2 JP5398945B2 (ja) 2014-01-29

Family

ID=8180193

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2002582991A Expired - Fee Related JP5398945B2 (ja) 2001-04-23 2002-04-23 TcおよびRe標識放射活性グリコシル化オクトレオチド誘導体
JP2009228998A Withdrawn JP2010001313A (ja) 2001-04-23 2009-09-30 TcおよびRe標識放射活性グリコシル化オクトレオチド誘導体
JP2013023001A Pending JP2013100349A (ja) 2001-04-23 2013-02-08 TcおよびRe標識放射活性グリコシル化オクトレオチド誘導体

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2009228998A Withdrawn JP2010001313A (ja) 2001-04-23 2009-09-30 TcおよびRe標識放射活性グリコシル化オクトレオチド誘導体
JP2013023001A Pending JP2013100349A (ja) 2001-04-23 2013-02-08 TcおよびRe標識放射活性グリコシル化オクトレオチド誘導体

Country Status (11)

Country Link
US (2) US7589061B2 (https=)
EP (1) EP1381396B1 (https=)
JP (3) JP5398945B2 (https=)
AT (1) ATE427125T1 (https=)
AU (1) AU2002254691B8 (https=)
BR (1) BR0209074A (https=)
CA (1) CA2443273C (https=)
CZ (1) CZ20032872A3 (https=)
DE (1) DE60231801D1 (https=)
HU (1) HU228811B1 (https=)
WO (1) WO2002085418A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL157086A0 (en) * 2003-07-24 2004-02-08 Guy Patchornik Multivalent ligand complexes
US7956165B2 (en) 2003-07-24 2011-06-07 Affisink Biotechnology Ltd. Compositions and methods for purifying and crystallizing molecules of interest
CN102253174A (zh) * 2011-04-27 2011-11-23 江苏省原子医学研究所 一种受体显像剂标记的化学动力学研究的方法
AU2012302636B2 (en) * 2011-09-04 2016-09-15 Glytech, Inc. Glycosylated polypeptide and drug composition containing said polypeptide
BR112014004936A2 (pt) * 2011-09-04 2017-04-04 Glytech Inc polipeptídeo glicosilado e composição de drogas contendo referido polipeptídeo
PL3152226T3 (pl) * 2014-06-06 2019-10-31 Univ Muenchen Tech Modyfikowane cyklopentapeptydy i ich zastosowania
HRP20231458T1 (hr) 2017-01-12 2024-05-10 Radiomedix Inc. Liječenje stanica raka koje prekomjerno eksprimiraju receptore za somatostatin primjenom derivata oktreotida keliranih sa radioizotopima
CN113747927B (zh) * 2019-02-14 2024-10-18 德国癌症研究中心 包含淀粉酶可切割接头的前列腺特异性膜抗原(psma)配体
BR112023018676A2 (pt) 2021-03-18 2023-10-10 Seagen Inc Conjugado anticorpo-fármaco, composição farmacêutica, métodos de tratamento de uma doença ou condição e de um câncer, e, composição de conjugado ligante-fármaco

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL194729C (nl) * 1986-10-13 2003-01-07 Novartis Ag Werkwijze voor de bereiding van peptidealcoholen via vaste fase.
JP2544159B2 (ja) 1987-10-07 1996-10-16 ハウス食品株式会社 連続蒸煮装置
MY106120A (en) 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
US5590656A (en) * 1992-09-15 1997-01-07 The Ohio State University Research Foundation Application of peptide/cell receptor kinetics utilizing radiolabeled somatostatin congeners in the in situ, in vivo detection and differentiation of neoplastic tissue
US5968477A (en) 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
EP0799050B1 (en) 1994-12-07 2004-08-11 Neorx Corporation Radiolabeled annexin-galactose cluster conjugates
JPH10512852A (ja) 1994-12-07 1998-12-08 ネオルクス コーポレイション 放射性標識化アネキシン−ガラクトースクラスター複合体
US5753206A (en) * 1995-06-07 1998-05-19 Immunomedics, Inc. Radiometal-binding analogues of luteinizing hormone releasing hormone
AU1821397A (en) 1995-12-21 1997-11-07 Scripps Research Institute, The Targeted therapeutic or diagnostic agents and methods of making and using same
DE19654764A1 (de) 1996-12-30 1998-07-02 Boehringer Mannheim Gmbh Verfahren zur Herstellung eines Peptidgemisches
EP1068224B1 (en) 1998-03-31 2005-05-11 Bristol-Myers Squibb Pharma Company Pharmaceuticals for the imaging of angiogenic disorders
DE19910419A1 (de) 1999-03-10 2000-09-21 Aventis Pharma Gmbh Zielzellspezifische, multivalente Proteine (MVP)

Similar Documents

Publication Publication Date Title
Decristoforo et al. Preparation, 99mTc-labeling, and in vitro characterization of HYNIC and N3S modified RC-160 and [Tyr3] octreotide
EP0977579B1 (en) Gastrin receptor-avid peptide conjugates
Schibli et al. In vitro and in vivo evaluation of bidentate, water-soluble phosphine ligands as anchor groups for the organometallic fac-[99mTc (CO) 3]+-core
JP2005514321A5 (https=)
JP2013100349A (ja) TcおよびRe標識放射活性グリコシル化オクトレオチド誘導体
EP0248506A1 (en) Metal ion labeling of carrier molecules
Liu et al. Labeling biomolecules with radiorhenium-A review of the bifunctional chelators
WO1998047524A9 (en) Gastrin receptor-avid peptide conjugates
EP0730472B1 (en) Immobilized labelling method
AU2003239351A1 (en) Radiopharmaceutical formulations
JP2004524323A5 (https=)
EP0850072A1 (en) A method for preparing radiolabeled peptides
AU2002254691A1 (en) Tc and Re labeler radioactive glycosylated octreotide derivatives
Banerjee et al. N, N-Bis (2-mercaptoethyl) methylamine: a new coligand for Tc-99m labeling of hydrazinonicotinamide peptides
KR20250089506A (ko) 방사성 의약 조성물의 제조 방법
KR100238558B1 (ko) 단백질의 테크네튬-99m 표지화
Cooper Supertripodal ligands
Grimminger Rhenium (V)-carbohydrate complexes with amino acids
Laznickova Radiolabelling of receptor specific peptides for tumor imaging and therapy
JPH11505852A (ja) 隔離された画像診断剤
Ortner et al. The mixed ligand [2+ 1] approach: An easier way of labeling the [M (CO) 3]+ core (M= 99, 99MTC, RE)?
Koten et al. Structure and reactivities of copper (I) and silver (I) complexes of potentially quadridentate N4 and N2S2 donor ligands
JPH0759524B2 (ja) 放射性医薬品とその調製用高分子化合物
CA2199387A1 (en) Process for preparing macrocyclic chelating agents and formation of chelates and conjugates thereof
CA2225326A1 (en) A simple and efficient method to prepare technetium-99m labelled peptides